Interleukin 17 induced nitric oxide suppresses matrix synthesis and protects cartilage from matrix breakdown

Journal of Rheumatology

Volumn 29, Issue 8, 2002, Pages 1725-1736

  Cai, Liping ^a   Suboc, Pam ^a   Hogue, Deborah A ^a   Fei, David T W ^a   Filvaroff, Ellen H ^a  

^a MS 72B ^*  (United States)

Author keywords

Chondrocytes; Cytokines; Interleukins; Nitric oxide; Proteoglycans; Rheumatoid arthritis

Indexed keywords

AGGRECANASE; DEXAMETHASONE; INTERLEUKIN 1ALPHA; INTERLEUKIN 7; LEUKEMIA INHIBITORY FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ENZYME INHIBITOR; GELATINASE; INTERLEUKIN 17; MATRIX METALLOPROTEINASE; PROTEOGLYCAN; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; INFLAMMATION; JOINT DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RHEUMATOID ARTHRITIS; SWINE; AGED; ANIMAL; BIOSYNTHESIS; CARTILAGE CELL; CATTLE; CELL CULTURE; CULTURE MEDIUM; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; HUMAN; MALE; METABOLISM; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANIMAL; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; CHONDROCYTES; CULTURE MEDIA, CONDITIONED; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; FEMALE; GELATINASES; HUMAN; INTERLEUKIN-17; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGE; NITRIC OXIDE; PROTEOGLYCANS; STROMELYSIN 1; SWINE; ANIMALS; HUMANS; MATRIX METALLOPROTEINASE 3; MIDDLE AGED;

EID: 0036021158     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Nitric oxide and arthritis
2. The role of nitric oxide in inflammation and immunity
3. The role of nitric oxide in articular cartilage breakdown in osteoarthritis
4. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide
5. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate cultures
6. Nitric oxide and cartilage metabolism
7. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase
8. Reduction in the structural changes of experimental osteoarthritis by a nitric oxide inhibitor
9. Reduced cartilage proteoglycan loss during zymosaninduced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation
10. Inhibition of nitric oxide synthase (NOS) aggravates Staphylococcus aureus septicaemia and septic arthritis
11. Selective inhibition of inducible nitric oxide synthase exacerbates erosive joint disease
12. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis
13. Nitric oxide activates metalloprotease enzymes in articular cartilage
14. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1
15. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: A possible mechanism of pathological neovascularization in arthritis
16. Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage
17. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-1 beta and TNF-alpha, by human macrophages
18. Human interleukin-17: A T-cell derived proinflammatory cytokine produced by the rheumatoid synovium
19. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
20. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism
21. Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines
22. T-cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
23. Interleukin-17 induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB
24. IL-17s adopt a cystine knot fold: Structure and activity of a novel cytokine, IL-17F, implications for receptor binding
25. Detection of human leukemia inhibitory factor by monoclonal antibody based ELISA
26. A fluorometric assay for the measurement of nitrite in biological samples
27. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue
28. Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo
29. Natural bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the maintenance of proteoglycans in bovine articular cartilage explant cultures
30. Differential expression of aggrecanase and matrix metalloproteinase activity in chondrocytes isolated from bovine and porcine articular cartilage
31. L-N6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase
32. Nitric oxide and proteoglycan turnover in rabbit articular cartilage
33. Nitric oxide mediates interleukin-1 induced inhibition of glycosaminoglycan synthesis in rat articular cartilage
34. Nitric oxide inhibits aggrecan degradation in explant cultures of equine articular cartilage
35. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures
36. Nitric oxide downregulates interleukin 1 beta (IL-1beta) stimulated IL-6, IL-8, prostaglandin E2 production by human chondrocytes
37. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin 4
38. The ability of nitric oxide (NO) inhibitors to reverse an interleukin-1 (IL-1) induced depression of proteoglycan synthesis is age dependent
39. Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha
40. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages
41. Mitogen-activated protein kinase and nuclear factor kappaB together regulate interleukin-17-induced nitric oxide production in human osteoarthritic chondrocytes
42. The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: Possible role in osteoarthritic cartilage degradation
43. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis
44. Inhibition of alanyl-aminopeptidase induces MAP-kinase p42/ERK2 in the human T cell line KARPAS-299
45. Modulation of Wnt-5A expression by actinonin: Linkage of APN to the Wnt-pathway
46. Dual roles of Wnt signaling during chondrogenesis in the chicken limb